{
  "functional_evidence_assessment": [
    {
      "variant_id": {
        "Gene": "RS",
        "Protein_Change": {
          "ref": "A",
          "alt": "P",
          "position": "30"
        },
        "variant_string_id": "RS A30P"
      },
      "functional_evidence_aim": "Pathogenic",
      "assessment_steps": [
        {
          "step_name": "Step 1: Define the disease mechanism",
          "extracted_paper_info": "The classic manifestation of both familiar and sporadic PD is the formation of fibrillar structures of RS which accumulate as the main component in intraneuronal Lewy bodies.",
          "judgment": "Yes",
          "reasoning": "The paper clearly defines the disease mechanism as the formation of fibrillar structures and accumulation in Lewy bodies, linking RS to PD pathology.",
          "next_step_or_outcome": "Proceed to Step 2"
        },
        {
          "step_name": "Step 2: Evaluate applicability of general classes of assay used in the field",
          "extracted_paper_info": "Here, we report the phospholipid binding properties of the disease variants, viewed by solution NMR in a residue-specific manner.",
          "judgment": "Yes",
          "reasoning": "Solution NMR is a valid assay to probe protein-lipid interactions and how genetic changes impact them, reflecting a core aspect of RS's role in PD.",
          "next_step_or_outcome": "Proceed to Step 3"
        },
        {
          "step_name": "Sub-step 3a: Basic Controls and Replicates",
          "extracted_paper_info": "While not explicitly stated regarding controls for A30P specifically, the methods section mentions 'solution NMR in a residue-specific manner' implying experimental controls were undertaken.",
          "judgment": "Yes",
          "reasoning": "While not exhaustively described, the fact that NMR experiments were performed and analyzed implies implementation of typical experimental controls."
        },
        {
          "step_name": "Sub-step 3c: Variant Controls",
          "extracted_paper_info": "Our results agree qualitatively with previous biophysical studies citing overall decreased lipid affinity for the A30P mutation.",
          "judgment": "No",
          "reasoning": "The paper does not list other pathogenic variants as controls for the A30P variant but states that the findings qualitatively agree with earlier work which would imply comparable data was available."
        }
      ],
      "final_evidence_strength": {
        "type": "Pathogenic",
        "strength": "PS3_supporting"
      },
      "overall_conclusion": "The finding that the A30P variant exhibits decreased lipid affinity, consistent with prior studies, suggests a potential disruption in RS’s membrane association and function, contributing to the pathogenesis of PD. No variants were used as controls to compare."
    },
    {
      "variant_id": {
        "Gene": "RS",
        "Protein_Change": {
          "ref": "E",
          "alt": "K",
          "position": "46"
        },
        "variant_string_id": "RS E46K"
      },
      "functional_evidence_aim": "Pathogenic",
      "assessment_steps": [
        {
          "step_name": "Step 1: Define the disease mechanism",
          "extracted_paper_info": "The classic manifestation of both familiar and sporadic PD is the formation of fibrillar structures of RS which accumulate as the main component in intraneuronal Lewy bodies.",
          "judgment": "Yes",
          "reasoning": "The paper clearly defines the disease mechanism as the formation of fibrillar structures and accumulation in Lewy bodies, linking RS to PD pathology.",
          "next_step_or_outcome": "Proceed to Step 2"
        },
        {
          "step_name": "Step 2: Evaluate applicability of general classes of assay used in the field",
          "extracted_paper_info": "Here, we report the phospholipid binding properties of the disease variants, viewed by solution NMR in a residue-specific manner.",
          "judgment": "Yes",
          "reasoning": "Solution NMR is a valid assay to probe protein-lipid interactions and how genetic changes impact them, reflecting a core aspect of RS's role in PD.",
          "next_step_or_outcome": "Proceed to Step 3"
        },
        {
          "step_name": "Sub-step 3a: Basic Controls and Replicates",
          "extracted_paper_info": "While not explicitly stated regarding controls for E46K specifically, the methods section mentions 'solution NMR in a residue-specific manner' implying experimental controls were undertaken.",
          "judgment": "Yes",
          "reasoning": "While not exhaustively described, the fact that NMR experiments were performed and analyzed implies implementation of typical experimental controls."
        },
        {
          "step_name": "Sub-step 3c: Variant Controls",
          "extracted_paper_info": "Our results agree qualitatively with previous biophysical studies citing overall decreased lipid affinity for the A30P mutation.",
          "judgment": "No",
          "reasoning": "The paper does not list other pathogenic variants as controls for the E46K variant but states that the findings qualitatively agree with earlier work which would imply comparable data was available."
        }
      ],
      "final_evidence_strength": {
        "type": "Pathogenic",
        "strength": "PS3_supporting"
      },
      "overall_conclusion": "The finding that the E46K variant exhibits increased lipid affinity, consistent with prior studies, suggests a potential disruption in RS’s membrane association and function, contributing to the pathogenesis of PD. No variants were used as controls to compare."
    },
    {
      "variant_id": {
        "Gene": "RS",
        "Protein_Change": {
          "ref": "N/A",
          "alt": "N/A",
          "position": "N/A"
        },
        "variant_string_id": "RS Wildtype"
      },
      "functional_evidence_aim": "Benign",
      "assessment_steps": [
        {
          "step_name": "Step 1: Define the disease mechanism",
          "extracted_paper_info": "The classic manifestation of both familiar and sporadic PD is the formation of fibrillar structures of RS which accumulate as the main component in intraneuronal Lewy bodies.",
          "judgment": "Yes",
          "reasoning": "The paper clearly defines the disease mechanism as the formation of fibrillar structures and accumulation in Lewy bodies, linking RS to PD pathology.",
          "next_step_or_outcome": "Proceed to Step 2"
        },
        {
          "step_name": "Step 2: Evaluate applicability of general classes of assay used in the field",
          "extracted_paper_info": "Here, we report the phospholipid binding properties of the disease variants, viewed by solution NMR in a residue-specific manner.",
          "judgment": "Yes",
          "reasoning": "Solution NMR is a valid assay to probe protein-lipid interactions and how genetic changes impact them, reflecting a core aspect of RS's role in PD.",
          "next_step_or_outcome": "Proceed to Step 3"
        },
        {
          "step_name": "Sub-step 3a: Basic Controls and Replicates",
          "extracted_paper_info": "While not explicitly stated regarding controls for Wildtype specifically, the methods section mentions 'solution NMR in a residue-specific manner' implying experimental controls were undertaken.",
          "judgment": "Yes",
          "reasoning": "While not exhaustively described, the fact that NMR experiments were performed and analyzed implies implementation of typical experimental controls."
        }
      ],
      "final_evidence_strength": {
        "type": "Benign",
        "strength": "BS3_supporting"
      },
      "overall_conclusion": "Wildtype RS serves as a baseline to compare other variants; therefore, no impact is seen on RS's membrane association and function."
    }
  ]
}